While control, vehicle‐treated cells easily migrated through the scrape, GW9662‐treated cells failed to do so within 48 h, indicating that PPARG inhibition reduces the migration capacity of AML cells. The gene discussed is PPARG; the disease is acute myeloid leukemia.